Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
A Study Comparing Swallowed Flovent and Placebo in Patients With Eosinophilic Disorders
This study has been completed.
Study NCT00266578 Information provided by Children's Hospital Medical Center, Cincinnati
First Received on December 15, 2005. Last Updated on April 10, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Eosinophilic Esophagitis
Additional conditions recognized in this trial
Eosinophilia
Esophagitis
More general conditions related to this trial
Digestive System Diseases
Esophageal Diseases
Gastroenteritis
Gastrointestinal Diseases
Hematologic Diseases
Hypersensitivity
Hypersensitivity, Immediate
Immune System Diseases
Leukocyte Disorders
Interventions listed in this trial
Fluticasone Propionate
Additional drug interventions recognized in this trial
Fluticasone
More general drug interventions related to this trial
Anti-Allergic Agents
Anti-Asthmatic Agents
Anti-Inflammatory Agents
Autonomic Agents
Bronchodilator Agents
Dermatologic Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Respiratory System Agents
Therapeutic Uses
Sponsors listed in this trial
Marc Rothenberg
Back to top of Main Content
